GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » 111 Inc (NAS:YI) » Definitions » Debt-to-Asset

111 (YI) Debt-to-Asset : 0.14 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is 111 Debt-to-Asset?

111's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $53 Mil. 111's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $9 Mil. 111's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $433 Mil. 111's debt to asset for the quarter that ended in Dec. 2023 was 0.14.


111 Debt-to-Asset Historical Data

The historical data trend for 111's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

111 Debt-to-Asset Chart

111 Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial 0.11 0.11 0.16 0.10 0.14

111 Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.11 0.13 0.12 0.14

Competitive Comparison of 111's Debt-to-Asset

For the Medical Distribution subindustry, 111's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


111's Debt-to-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, 111's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where 111's Debt-to-Asset falls into.



111 Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

111's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(53.305 + 8.771) / 432.626
=0.14

111's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(53.305 + 8.771) / 432.626
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


111  (NAS:YI) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


111 Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of 111's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


111 (YI) Business Description

Traded in Other Exchanges
Address
No.295 ZuChongZhi Road, 3rd-5th Floors, Pudong New Area, Shanghai, CHN, 201203
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

111 (YI) Headlines

From GuruFocus